103 related articles for article (PubMed ID: 21820414)
1. Proteomic analysis of cancer stem cells in human prostate cancer cells.
Lee EK; Cho H; Kim CW
Biochem Biophys Res Commun; 2011 Aug; 412(2):279-85. PubMed ID: 21820414
[TBL] [Abstract][Full Text] [Related]
2. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells.
Patrawala L; Calhoun-Davis T; Schneider-Broussard R; Tang DG
Cancer Res; 2007 Jul; 67(14):6796-805. PubMed ID: 17638891
[TBL] [Abstract][Full Text] [Related]
3. ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell lines.
Yu C; Yao Z; Dai J; Zhang H; Escara-Wilke J; Zhang X; Keller ET
In Vivo; 2011; 25(1):69-76. PubMed ID: 21282737
[TBL] [Abstract][Full Text] [Related]
4. Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line.
Rowehl RA; Crawford H; Dufour A; Ju J; Botchkina GI
Cancer Genomics Proteomics; 2008; 5(6):301-10. PubMed ID: 19287071
[TBL] [Abstract][Full Text] [Related]
5. CD44 and SSEA-4 positive cells in an oral cancer cell line HSC-4 possess cancer stem-like cell characteristics.
Noto Z; Yoshida T; Okabe M; Koike C; Fathy M; Tsuno H; Tomihara K; Arai N; Noguchi M; Nikaido T
Oral Oncol; 2013 Aug; 49(8):787-95. PubMed ID: 23768762
[TBL] [Abstract][Full Text] [Related]
6. Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer.
Palapattu GS; Wu C; Silvers CR; Martin HB; Williams K; Salamone L; Bushnell T; Huang LS; Yang Q; Huang J
Prostate; 2009 May; 69(7):787-98. PubMed ID: 19189306
[TBL] [Abstract][Full Text] [Related]
7. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer.
Pries R; Witrkopf N; Trenkle T; Nitsch SM; Wollenberg B
In Vivo; 2008; 22(1):89-92. PubMed ID: 18396788
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line.
Zhang H; Li W; Nan F; Ren F; Wang H; Xu Y; Zhang F
Biochem Biophys Res Commun; 2011 Jan; 404(1):273-8. PubMed ID: 21130073
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer stem cells and their potential roles in metastasis.
Li H; Tang DG
J Surg Oncol; 2011 May; 103(6):558-62. PubMed ID: 21480250
[TBL] [Abstract][Full Text] [Related]
10. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer stem/progenitor cells: identification, characterization, and implications.
Tang DG; Patrawala L; Calhoun T; Bhatia B; Choy G; Schneider-Broussard R; Jeter C
Mol Carcinog; 2007 Jan; 46(1):1-14. PubMed ID: 16921491
[TBL] [Abstract][Full Text] [Related]
12. Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells.
Miki J; Rhim JS
Prostate Cancer Prostatic Dis; 2008; 11(1):32-9. PubMed ID: 17984999
[TBL] [Abstract][Full Text] [Related]
13. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells.
Patrawala L; Calhoun T; Schneider-Broussard R; Li H; Bhatia B; Tang S; Reilly JG; Chandra D; Zhou J; Claypool K; Coghlan L; Tang DG
Oncogene; 2006 Mar; 25(12):1696-708. PubMed ID: 16449977
[TBL] [Abstract][Full Text] [Related]
14. CD44 as a molecular marker to screen cancer stem cells in hypopharyngeal cancer.
Shen C; Xiang M; Nie C; Hu H; Ma Y; Wu H
Acta Otolaryngol; 2013 Nov; 133(11):1219-26. PubMed ID: 23837451
[TBL] [Abstract][Full Text] [Related]
15. Poly r(C) binding protein-1 is central to maintenance of cancer stem cells in prostate cancer cells.
Chen Q; Cai ZK; Chen YB; Gu M; Zheng DC; Zhou J; Wang Z
Cell Physiol Biochem; 2015; 35(3):1052-61. PubMed ID: 25661993
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of human adipose stem cells in a cancer stem cell-like gastric cancer cell model.
Liu G; Neumeister M; Reichensperger J; Yang RD
Int J Oncol; 2013 Oct; 43(4):1301-9. PubMed ID: 23900519
[TBL] [Abstract][Full Text] [Related]
17. CD44-positive colorectal adenoma cells express the potential stem cell markers musashi antigen (msi1) and ephrin B2 receptor (EphB2).
Schulenburg A; Cech P; Herbacek I; Marian B; Wrba F; Valent P; Ulrich-Pur H
J Pathol; 2007 Oct; 213(2):152-60. PubMed ID: 17708598
[TBL] [Abstract][Full Text] [Related]
18. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
[TBL] [Abstract][Full Text] [Related]
19. Proteomics for the identification of new prostate cancer biomarkers.
Ornstein DK; Tyson DR
Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055
[TBL] [Abstract][Full Text] [Related]
20. Significance of CD90+ cancer stem cells in human liver cancer.
Yang ZF; Ho DW; Ng MN; Lau CK; Yu WC; Ngai P; Chu PW; Lam CT; Poon RT; Fan ST
Cancer Cell; 2008 Feb; 13(2):153-66. PubMed ID: 18242515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]